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Heritability and association with distinct genetic loci
of erythropoietin levels in the general population
Erythropoietin (Epo)-regulated red blood cell (RBC)
homeostasis is crucial for oxygen delivery in vertebrates,
and Epo over- or under-production causes erythrocytosis
or anemia, respectively. Plasma Epo levels are usually
very low and characterized by circadian fluctuations and
strong induction upon acute exposure to low oxygen
conditions such as inspiratory hypoxia or blood loss.
Considering the high prevalence of various forms of ane-
mia worldwide as well as the fact that the majority of
erythrocytosis cases are of unknown origin, surprisingly
little is known about the genetic determinants of circulat-
ing Epo levels. While a number of genome-wide associa-
tion studies (GWAS) could link RBC traits such as RBC
size, hemoglobin (Hb) content and hematocrit levels to
single-nucleotide polymorphisms (SNP), only few studies
analyzed circulating Epo levels. Some specific studies
focused on aging populations with gradually decreasing
renal function,1 Epo levels after kidney transplantation,2
or the (lack of) sex-specific differences in chronically ane-
mic patients.3 However, none of these initial analyses
have been performed in a population-based cohort which
would have the advantage of a high external validity of
the findings. A first GWAS with circulating Epo levels
was performed in a large (6,984 participants) non-family-
based Dutch cohort.4 Epo values were obtained from
6,777 participants and 2,691 were used for GWAS which
identified a locus comprising the HBS1L and MYB genes
as most likely targets, but no replication cohort was avail-
able for validation by an independent study.
We analyzed RBC traits in the Swiss Kidney Project on
Genes in Hypertension (SKIPOGH) cohort, including
1,109 adult participants from the general population with
well characterized physiological parameters.5
Participants' characteristics by sex, including RBC traits,
are shown in the Online Supplementary Table S1. An
important aspect of the SKIPOGH cohort is its family-
based design (average family size in the SKIPOGH cohort
is four) which allows for the analysis of heritability, i.e.,
the genetic component of a given phenotypic trait. As
shown in Table 1, a high heritability of RBC traits was
observed in the SKIPOGH cohort. Adding a sibling com-
ponent of variance had little impact on the heritability
estimates, suggesting the absence of significant domi-
nance variance and shared environmental components
across siblings. 
These initial results motivated us to analyze Epo blood
plasma levels which, according to our knowledge, had
not been studied in such a family-based cohort before.
Epo was determined in heparin-treated plasma of a total
of 1,066 (96%) participants. For 1,020 samples both
duplicate measurements (replicate correlation r=0.998)
and phenotypic data were obtained. Following the elimi-
nation of 14 extreme outliers, the remaining 1,006 (91%)
unadjusted Epo values (Figure 1A) corresponded to the
reported reference values of 2.8 to 17.9 IU/L (based on
2,506 samples).4 Over a normal Hb range of 135-175 g/L
and 120-155 g/L for men and women, respectively, the
range of Epo was 4-24 IU/L without any significant dif-
ference between sex (Online Supplementary Table S1). A
quadratic fit with Hb levels was found (Figure 1B), which
may be explained by anemia-responsive Epo at low Hb
levels and hormone-responsive Hb at high Epo levels. As
shown in Table 2, Epo levels were significantly heritable,
without significant sibling or marital components of vari-
ance, suggesting the absence of significant dominance
variance and shared environmental variance. 
We next perfomed a GWAS of 2.5x106 genotyped SNP
and an additional 4.0x106 of imputed SNP with the mean
of duplicate Epo measurements of 872 (79%) individuals,
corrected for age, sex, center and familiarity. Figure 1C
shows the level of significance of the association
between each of the 6.5x106 markers and the normalized
Epo levels. No signal reached P<5x10-8, the commonly
used level of genome-wide significance (Online
Supplementary Table S2). However, a few SNP fell into
the suggestive significance zone (P<10-5) and the top hit,
lying on chromosome 15, reached P=1.05x10-7 at
rs413451. As shown in Figure 1D, the SNP identified on
chromosome 15 are located within a linkage disequilibri-
um (LD) block comprising the last exons of mitogen-acti-
vated protein kinase kinase 5 (MAP2K5), the whole SKI
family transcriptional corepressor 1 (SKOR1) gene and
the 5' upstream and promoter regions of protein inhibitor
of activated STAT1 (PIAS1). PIAS1 is a SUMO E3 ligase
affecting STAT1 and NFκB pathways. The PIAS1 locus
has previously been associated with body mass index
(BMI) and related phenotypes (weight, waist circumfer-
ence, obesity, predicted visceral adipose tissue), as well as
smoking-related phenotypes (initiation age, smoking sta-
tus) and age at menarche.6-8 According to the MR-Base
PHEWAS database in the UK Biobank cohort several
RBC-related phenotypes were also associated with the
MAP2K5-SKOR1-PIAS1 locus, further suggesting that it
could be directly associated with Epo levels. 
Figure 1E shows the significance of the association for
the SNP present at the previously associated locus
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Table 1. Heritability estimates of red blood cell indices in the SKIPOGH cohort. 
                                                 Model 1                                                                       Model 2 
                                                h2 ± SEM                                                P                   h2 ± SEM                                                P
Hemoglobin                                   0.40 ± 0.05                     0.52                      <1.0x10-7                0.37 ± 0.06                     0.52                      <1.0x10-7
Hematocrit                                    0.37 ± 0.06                     0.57                          0.001                    0.33 ± 0.07                     0.57                      <1.0x10-7
RBC count                                      0.50 ± 0.05                     0.67                      <1.0x10-6                0.47 ± 0.06                     0.66                      <1.0x10-7
MCV                                                 0.68 ± 0.04                     0.59                      <1.0x10-7                0.68 ± 0.05                     0.59                      <1.0x10-7
MCH                                                0.63 ± 0.05                     0.52                      <1.0x10-5                0.61 ± 0.06                     0.51                      <1.0x10-5
MCHC                                             0.60 ± 0.06                     0.94                      <1.0x10-5                0.46 ± 0.06                     0.93                      <1.0x10-7
RDW                                                0.38 ± 0.07                     0.20                        <0.001                  0.36 ± 0.08                     0.20                        <0.001
Models are adjusted for age, sex and center. Model 1, no sibship component of variance; model 2, including a sibship component of variance (which captures dominance
genetic variance and shared environmental components between siblings). h2, heritability; λ, power transformation: (λ = 0) and (λ = 1) correspond to log and no transfor-
mations, respectively. SKIPOGH: Swiss Kidney Project on Genes in Hypertension; RBC: red blood cell; MCV: mean corpuscular volume; MCH: mean cell hemoglobin; MCHC:
mean corpuscular hemoglobin concentration; RDW: red blood cell distribution width. 
HBS1L-MYB. Interestingly, the top common SNP of our
study (rs9402685) and the associated HBS1L-MYB locus
showed a robust association with Epo levels (P=1.46
x10-4), confirming the previously published results.4 The
SNP rs1617640 of the EPO locus itself has been reported
to be associated with low Epo serum levels in predialysis
chronic kidney disease patients,9 but neither this SNP nor
any other SNP of the EPO locus (lowest P=0.17 at
rs7789679) were associated with Epo levels in our study. 
While the recently reported SNP rs1130864 of the 
C-reactive protein (CRP) locus did not associate with Epo
levels in our study (P=0.69), it associated with altered
Epo levels in dried neonatal blood spots.10 In the same
study, EPO SNP heritability was approximately zero.
However, at this age blood volume and hematocrit are
different from the adult stage, the liver-to-kidney switch
of Epo synthesis is still ongoing, and the method for Epo
determination was much less precise, altogether explain-
ing the discrepancy.
The result obtained with our top SNP of the 
HBS1L-MYB locus (rs9402685) was meta-analyzed with
results publicly available from Beverborg et al.4 The com-
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Figure 1. Genome-wide association studies of erythropoietin plasma levels in the SKIPOGH cohort. (A) Histogram distribution of the mean values of duplicate
erythropoietin (Epo) measurements in the blood plasma of 1,006 participants. (B) Correlation between Epo and hemoglobin (Hb) levels in the SKIPOGH cohort.
(C) Manhattan plot showing the –log10 (P-value) of the association between Epo plasma levels and 6.4x10
6 single-nucleotide polymorphisms (SNP) in 872 sam-
ples following correction for sex, age and center. The blue line shows the indicative suggestive threshold of P<10-5. Markers are ranked by chromosome and
positions. The green dot on chromosome 6 shows the top SNP at the HBS1L-MYB locus, and the green dot on chromosome 15 shows the top SNP at the
MAP2K5-SKOR1-PIAS1 locus. (D) Region around the top SNP rs413451 in the MAP2K5-SKOR1-PIAS1 locus. (E) Region around the top SNP rs9402685 in the
HBS1L-MYB intergenic locus which is the reference SNP found in our study. SKIPOGH: Swiss Kidney Project on Genes in Hypertension. 
A
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Table 2. Heritability of plasma erythropoietin levels in the SKIPOGH cohort. 
Variance components                                         Adjustment                                  Heritability ± SD                                          P
P* - M - S                                                                    Age, sex, center                                            0.40 ± 0.07                                                    <0.001
P* - M                                                                           Age, sex, center                                            0.41 ± 0.07                                                    <0.001
P* - S                                                                            Age, sex, center                                            0.39 ± 0.07                                                    <0.001
P*                                                                                  Age, sex, center                                            0.40 ± 0.06                                                    <0.001
P* - M - S                                                                       Fully adjusted                                              0.51 ± 0.08                                                    <0.001
P* - M                                                                             Fully adjusted                                              0.52 ± 0.07                                                    <0.001
P* - S                                                                              Fully adjusted                                              0.48 ± 0.07                                                    <0.001
P*                                                                                    Fully adjusted                                              0.49 ± 0.06                                                    <0.001
Shown is the heritability of ln(Epo) ± standard deviation. Narrow sense heritability was estimated from family data using the ASSOC program in the Statistical Analysis in
Genetic Epidemiology software package (Case Western Reserve University). Epo: erythropoietin; SD: standard devaition; P: polygenic; M: marital; S: sibling. Fully adjusted:
age, sex, center, current smoker (yes/no), hemoglobin level, eGFR (ckd-epi formula). *Only the polygenic component of the variance was significantly different from 0 in
all models. SKIPOGH: Swiss Kidney Project on Genes in Hypertension.
bined P-value reached 1.78x10-23, which was more signif-
icant than in any of the two individual studies (1.46x10-4
and 1.09x10-20, respectively). The intergenic locus
between the HBS1L (GTP-binding elongation factor) and
MYB (myeloblastosis oncogene) genes had previously
been reported to be associated with deregulated HbF in a
Chinese β-thalassemia anemia population, a favorable
genetic environment for the selection of otherwise ery-
throcytosis-causing mutations.11 Several erythropoietic
transcription factors have been shown to be prevented
from binding to the mutant locus, resulting in lowered
Myb gene activation and increased HbF synthesis.12 A link
to increased Epo levels, suggesting secondary (Epo-
dependent) rather than primary (Epo-independent) ery-
throcytosis, has not been made in these original reports.
GWAS performed in a UK Biobank cohort and a Japanese
population showed significant associations between the
HBS1L-MYB locus and RBC-related phenotypes.13,14
Together with our direct replication of the association
with circulating Epo levels in a Swiss cohort, these results
further confirm the implication of this locus in erythro-
poiesis, maybe both upstream as well as downstream of
Epo. However, it is currently not known whether the
HBS1L-MYB locus also contributes to the heritable
genetic determinants triggering Epo levels. 
A gene score  and a pathway analysis, run with the
PASCAL algorithm based on our GWAS results, failed to
show any significant pathway after applying multiple
testing corrections. 
For a candidate-based approach, we selected 33 genes
known to influence EPO gene expression. The associa-
tion gene scores from PASCAL could be retrieved from 30
of these 33 genes. Bonferroni correction applied to the
number of genes observed led to a significance threshold
of 1.67x10-3. The OS9 gene was significantly associated
with a gene score association P-value of 1.47x10-3 (Online
Supplementary Table S3). OS-9 is known to interact with
both HIF-1α and HIF prolyl-4-hydroxylases, promoting
HIF-1α degradation. Interestingly, a OS9 gene variant has
previously been reported to be associated with erythro-
cytosis in a single patient.15
The top SNP of the MAP2K5-SKOR1-PIAS1 locus
(rs413451) was subjected to a phenome-wide association
study (PHEWAS) using the MR-Base database of the UK
Biobank cohort. SNP rs413451 was most significantly
associated with BMI-related phenotypes. Interestingly,
Hb concentration (P=6.35x10-6), reticulocyte count
(P=7.28x10-6), hematocrit (P=1.16x10-4), reticulocyte frac-
tion of RBC (P=2.04x10-4) and RBC count 
(P= 2.23x10-4) were also highly associated with rs413451.
Circulatory Epo levels were not available in the UK
Biobank. However, the GWAS Atlas database showed a
preponderance of BMI-related phenotypes for most sig-
nificant studies in the database of published GWAS.
In summary, our study revealed the heritability of cir-
culating Epo levels, validated a previously published
association with the HBS1L-MYB locus, and identified an
association with the MAP2K5-SKOR1-PIAS1 locus. From
the list of candidate Epo-regulatory genes, OS9 showed
the highest association with circulating Epo levels.
However, the two latter associations require replication,
and the functional implication of all three loci in Epo reg-
ulation needs to be further investigated. Regarding the
idiopathic nature of the majority of erythrocytosis cases,
we suggest that especially in patients with high Epo lev-
els, indicative of secondary erythrocytosis, these loci
should be considered for further investigation.
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